8-K: Ludwig Enterprises Secures $250K Convertible Note, Warrant Deal

Sentiment:

Securities Issuance and Financing Agreement


Ludwig Enterprises, Inc. has secured $250,000 in financing through a convertible promissory note and a common stock purchase warrant from Alumni Capital LP.

Capital raiseLudwig Enterprises, Inc. issued a convertible promissory note with an original principal amount of $250,000 to Alumni Capital LP.The Company also issued a common stock purchase warrant exercisable for up to 4,166,667 shares of Common Stock at an exercise price of $0.06 per share.The aggregate purchase price for the note and warrant was $200,000.The proceeds are intended for general corporate purposes.The Investor has a participation right to acquire a pro rata portion (50% of the basic amount) of any future equity or equity-linked placements by the Company.
Worse than expectedThe convertible note was issued at a significant discount ($200,000 for $250,000 principal), indicating a high cost of capital for the Company.The conversion price for the note is highly dilutive, set at 70% of the lowest traded price during a 20-day period, which can lead to substantial dilution for existing shareholders if the stock price declines.The Company is subject to a broad range of "Events of Default" that could trigger immediate and potentially costly redemption obligations.The Company is restricted from certain future financing activities, such as "Variable Rate Transactions," which could limit its flexibility in raising capital under more favorable terms in the future.

Summary

  • Ludwig Enterprises, Inc. (the Company) entered into a Securities Purchase Agreement with Alumni Capital LP (the Investor) on February 5, 2026.
  • The Company issued a convertible promissory note (the Note) with an original principal amount of $250,000.
  • The Company also issued a common stock purchase warrant (the Warrant) exercisable for up to 4,166,667 shares of Common Stock at an exercise price of $0.06 per share.
  • The aggregate purchase price paid by the Investor for both the Note and the Warrant was $200,000, indicating an original issue discount.
  • The Note matures on May 4, 2026, and is convertible into common shares at a conversion price equal to 70% of the lowest traded price during the 20 business days immediately prior to delivery of a conversion notice, subject to certain conditions.
  • The Warrant is exercisable from February 5, 2026, and expires on February 5, 2031.
  • Proceeds from the sale are designated for general corporate purposes, explicitly excluding debt satisfaction (unless scheduled), security redemption/repurchase, or litigation settlement.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a highly dilutive and potentially costly financing arrangement, reflecting challenges in securing less onerous capital. While it provides immediate funds, the terms are unfavorable for existing shareholders.

Positives

  • Secured $250,000 in financing, providing immediate capital for general corporate purposes.
  • The convertible note structure offers flexibility for the Company to potentially convert debt to equity.
  • The Company maintains a participation right for the Investor in future equity placements, potentially streamlining future capital raises.

Negatives

  • The Note was issued at a discount, with a $200,000 purchase price for a $250,000 principal amount, indicating a higher effective cost of capital.
  • The conversion price for the Note is set at 70% of the lowest traded price during the 20 business days immediately prior to conversion, which is highly dilutive for existing shareholders if the stock price declines.
  • A high default interest rate of 15% per annum applies if an Event of Default occurs.
  • The Company is restricted from engaging in "Variable Rate Transactions" (securities with market-based or reset conversion/exercise prices), limiting future financing flexibility.
  • The Company is restricted from effecting stock combinations or reverse stock splits without prior written consent of Required Holders, unless for minimum bid price compliance, which could hinder efforts to maintain listing or improve stock perception.

Risks

  • Dilution Risk: The conversion price of the Note (70% of the lowest traded price) and the exercise of the Warrant (4,166,667 shares at $0.06) could lead to significant dilution for existing shareholders, especially if the stock price falls.
  • Default Risk: Numerous events of default are defined, including failure to register securities, trading suspension, conversion/delivery failures, failure to pay amounts due (>$500,000 for other indebtedness, 5 days for default interest/late charges), failure to remove restrictive legends, bankruptcy, judgments over $1,000,000, breach of covenants, material adverse effect, litigation against management, invalidity of transaction documents, public information failure, and voluntary delisting, which could trigger immediate redemption obligations at a premium.
  • Liquidity Risk: If the Company fails to deliver Common Shares upon conversion or exercise, it may be required to pay cash for "Authorized Failure Shares" or compensate the Holder for "Buy-In" costs, potentially straining cash reserves.
  • Financing Restrictions: Covenants restrict the Company from certain actions, such as issuing other notes or securities that would cause a breach, or engaging in variable rate transactions, which could limit its flexibility in raising capital under more favorable terms in the future.
  • Shareholder Approval Risk: If the number of authorized shares is insufficient to meet the "Required Reserve Amount" for conversions/exercises, the Company must seek shareholder approval to increase authorized shares, which may not be guaranteed.
  • Legal and Regulatory Risk: Failure to comply with SEC reporting requirements or Principal Market listing rules could trigger events of default or public information failure payments.
  • Market Price Volatility: The conversion price and redemption prices are tied to the Company's stock price, making the Company vulnerable to market fluctuations.

Future Outlook

The filing primarily details a financing transaction and its terms, rather than providing explicit forward-looking statements or guidance on future performance. However, the use of proceeds for "general corporate purposes" implies an intent to continue and potentially expand operations. The company's covenants regarding maintaining listing and timely SEC filings suggest an ongoing commitment to public company status.

Management Comments

  • The Company will apply Section 1273(c)(2) of the Code as if the Note and the Warrant constitute an investment unit for purposes of Section 1273(c)(2) of the Code.
  • The Company will use the proceeds from the sale of the Securities for general corporate purposes, but not... for the satisfaction of any indebtedness... the redemption or repurchase of any securities... or the settlement of any outstanding litigation.
  • The Company understands and acknowledges that the number of Underlying Securities will increase in certain circumstances. The Company further acknowledges that its obligation to issue the Conversion Shares... and the Warrant Shares... is absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company.

Industry Context

StockSavvy.ai notes that this financing structure, involving a convertible note with a deeply discounted conversion price and an accompanying warrant, is often utilized by smaller public companies, particularly those on OTC markets, to raise capital when traditional debt or equity financing might be challenging or more expensive. The dilutive nature of the conversion terms (70% of lowest traded price) is a common feature in such "death spiral" or "toxic" financing arrangements, reflecting the perceived risk by the investor and potentially significant future dilution for existing shareholders. The restrictions on "Variable Rate Transactions" are also typical in such agreements to protect the investor from further dilutive financing structures.

Comparison to Industry Standards

  • The issuance of a convertible note at a discount (purchase price $200,000 for $250,000 principal) is not uncommon for micro-cap or distressed companies seeking capital, but it reflects a higher cost of capital compared to investment-grade corporate bonds or traditional bank loans. For example, a well-established company like Apple or Microsoft would typically secure financing at much lower effective interest rates and without such significant discounts.
  • The conversion price of 70% of the lowest traded price during a 20-day period is significantly more aggressive and dilutive than standard convertible debt terms seen in larger, more stable companies, which usually feature conversion premiums (e.g., 20-30% above current market price). This type of "ratchet" conversion mechanism is often associated with highly speculative investments.
  • The warrant exercise price of $0.06 per share, combined with the 4,166,667 shares, represents a substantial potential future dilution, especially given the company's current outstanding share count of 162,569,807 shares and 737,390,429 shares issuable from other convertible securities. This level of potential dilution is far greater than what would be considered standard for a growth-stage company with strong fundamentals.
  • The extensive list of "Events of Default" and the associated remedies, including redemption at a premium, are typical of high-risk debt instruments designed to protect the lender in volatile situations, contrasting with simpler, less restrictive covenants in financing for financially robust entities.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Financing CovenantsThe Company is subject to various covenants, including restrictions on restricted payments, investments, redemptions, cash dividends, asset transfers, changes in business nature, and corporate structure. It must also maintain existence, properties, intellectual property, and insurance.2026-02-05These covenants impose significant limitations on the Company's operational and financial flexibility, designed to protect the investor's interests.
Shareholder Approval RequirementsThe Company must obtain shareholder approval to increase authorized common shares if the current reserve is insufficient for conversions/exercises, and generally cannot effect stock combinations/reverse splits without Required Holders' consent (unless for minimum bid price compliance).2026-02-05This impacts the Company's ability to manage its capital structure without investor approval, potentially hindering strategic moves.
PCAOB Registered Auditor RequirementThe Company must engage an independent auditor registered with the Public Company Accounting Oversight Board (PCAOB) as long as any Notes remain outstanding.2026-02-05Ensures higher standards of financial auditing and transparency, beneficial for investor confidence but potentially increasing compliance costs.

Stakeholder Impact

  • Shareholders: Significant potential for dilution due to the convertible note's low conversion price (70% of lowest traded price) and the large number of shares issuable upon warrant exercise. Existing shareholders' equity interest could be substantially reduced.
  • Creditors (other than Alumni Capital LP): The Note payments are senior to all other indebtedness except for existing convertible promissory notes listed on Schedule 15(a), which rank pari passu. This could impact the recovery prospects of junior creditors in a default scenario.
  • Company Management: Management's operational and financial flexibility is constrained by numerous covenants, including restrictions on asset transfers, changes in business, and capital structure adjustments.
  • Alumni Capital LP (Investor): Gains a senior position in the Company's capital structure, significant potential for equity upside through conversion/exercise, and strong protective provisions (e.g., default remedies, anti-dilution, participation rights).

Next Steps

  • The Company must timely file all reports required by the 1934 Act and the Principal Market.
  • The Company must reserve 100% of the maximum number of common shares necessary to effect the conversion of the Note and exercise of the Warrant.
  • If authorized shares are insufficient, the Company must take action to increase them, including potentially holding a shareholder meeting within 30 days.
  • The Company must publicly disclose the material terms of the transaction via a press release and an 8-K filing.
  • The Company must maintain a transfer agent that participates in the DTC Fast Automated Securities Transfer Program (FAST).

Key Dates

DateDescription
2026-01-05Subscription Date (as defined in the Note and Warrant, but the Purchase Agreement states this as the Execution Date for the agreement itself).
2026-02-05Issuance Date of the Convertible Promissory Note and Common Stock Purchase Warrant; also the Initial Exercise Date for the Warrant and the Execution Date of the Securities Purchase Agreement.
2026-05-04Maturity Date of the Convertible Promissory Note.
2031-02-05Termination Date (expiration) of the Common Stock Purchase Warrant (five-year anniversary of Initial Exercise Date).

Recommendation

sell

The terms of this financing agreement are highly unfavorable for existing shareholders. The convertible note was issued at a discount, and its conversion price is set at a deeply dilutive 70% of the lowest traded price, which will likely lead to substantial dilution. The accompanying warrant also represents significant potential dilution. These terms suggest the company is in a weak bargaining position, indicating underlying financial distress or significant operational challenges. The extensive covenants and default provisions further highlight the high risk perceived by the investor. For a seasoned investor, this type of financing often signals a "death spiral" scenario where continuous dilution erodes shareholder value, making a "sell" recommendation prudent to avoid further losses.

Keywords

Convertible Note, Promissory Note, Warrant, Equity Financing, Capital Raise, SEC Filing, 8-K, Alumni Capital LP, Ludwig Enterprises, Dilution, Corporate Governance, Debt Financing, Stock Purchase Agreement, OTC Markets

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.